DK0866876T3 - Fremgangsmåde til fremstilling af rekombinante proteiner i E.coli ved hjælp af fermentering i høje celletætheder - Google Patents

Fremgangsmåde til fremstilling af rekombinante proteiner i E.coli ved hjælp af fermentering i høje celletætheder

Info

Publication number
DK0866876T3
DK0866876T3 DK96941047T DK96941047T DK0866876T3 DK 0866876 T3 DK0866876 T3 DK 0866876T3 DK 96941047 T DK96941047 T DK 96941047T DK 96941047 T DK96941047 T DK 96941047T DK 0866876 T3 DK0866876 T3 DK 0866876T3
Authority
DK
Denmark
Prior art keywords
coli
preparation
recombinant proteins
density fermentation
fermentation
Prior art date
Application number
DK96941047T
Other languages
English (en)
Inventor
Wolfgang Strittmatter
Siegfried Matzku
Dieter Riesenberg
Uwe Horn
Uwe Knuepfer
Marian Kujau
Rolf Wenderoth
Andreas Plueckthun
Anke Krebber
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK0866876T3 publication Critical patent/DK0866876T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK96941047T 1995-12-11 1996-11-28 Fremgangsmåde til fremstilling af rekombinante proteiner i E.coli ved hjælp af fermentering i høje celletætheder DK0866876T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95119478 1995-12-11
PCT/EP1996/005260 WO1997021829A1 (de) 1995-12-11 1996-11-28 Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte-fermentation

Publications (1)

Publication Number Publication Date
DK0866876T3 true DK0866876T3 (da) 2002-05-27

Family

ID=8219878

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96941047T DK0866876T3 (da) 1995-12-11 1996-11-28 Fremgangsmåde til fremstilling af rekombinante proteiner i E.coli ved hjælp af fermentering i høje celletætheder

Country Status (24)

Country Link
US (1) US6410270B1 (da)
EP (1) EP0866876B1 (da)
JP (2) JP4101879B2 (da)
KR (1) KR100444735B1 (da)
CN (1) CN1117160C (da)
AR (1) AR005035A1 (da)
AT (1) ATE213271T1 (da)
AU (1) AU716612B2 (da)
BR (1) BR9611937A (da)
CA (1) CA2240097C (da)
CZ (1) CZ291415B6 (da)
DE (1) DE59608743D1 (da)
DK (1) DK0866876T3 (da)
ES (1) ES2171752T3 (da)
HU (1) HU227945B1 (da)
NO (1) NO319090B1 (da)
PL (1) PL185665B1 (da)
PT (1) PT866876E (da)
RU (1) RU2201455C2 (da)
SI (1) SI0866876T1 (da)
SK (1) SK283169B6 (da)
UA (1) UA61066C2 (da)
WO (1) WO1997021829A1 (da)
ZA (1) ZA9610384B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715895D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
AU1223600A (en) 1998-10-28 2000-05-15 Genentech Inc. Process
EP1332222B1 (en) 2000-11-03 2009-03-25 Genentech, Inc. Metabolic rate shifts in fermentations expressing recombinant proteins
JP4304336B2 (ja) * 2001-07-06 2009-07-29 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング タンパク質の折りたたみを監視および調節することにより細菌におけるタンパク質の発現を改善する方法
JP2007530013A (ja) * 2003-12-12 2007-11-01 コンジュゴン インコーポレーティッド 緻密に調節された遺伝子発現のためのシステム
WO2005066340A1 (en) * 2003-12-23 2005-07-21 Council Of Scientific And Industrial Research Process for producing streptokinase using genetically modified escherichia coli
CA2592390A1 (en) 2004-12-22 2006-06-29 Genentech, Inc. Methods for producing soluble multi-membrane-spanning proteins
WO2008013943A2 (en) * 2006-07-27 2008-01-31 Wyeth High-cell density fed-batch fermentation process for producing recombinant protein
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
BRPI0716762A2 (pt) 2006-09-13 2013-09-24 Abbott Lab melhorias da cultura celular
ES2670368T3 (es) 2008-09-15 2018-05-30 F. Hoffmann-La Roche Ag Composiciones y procedimientos para regular la osmolaridad celular
CA2769010C (en) * 2009-07-28 2015-10-20 Mitsui Chemicals, Inc. Method for producing lactic acid
BR112012018956B1 (pt) * 2010-02-01 2022-05-31 Digna Biotech, S.L. Processo para produção de uma proteína interferon alfa 5
ES2558751T3 (es) 2010-08-30 2016-02-08 F. Hoffmann-La Roche Ag Alimento alcalino
KR101252150B1 (ko) * 2010-11-18 2013-04-08 한국과학기술원 재조합 ＤＮＡ 분자 클로닝을 위한 알데히드 환원효소 ＹｑｈＤ 유전자를 포함하는 자살 벡터
RU2507736C2 (ru) * 2011-01-11 2014-02-27 Федеральное государственное бюджетное учреждение науки Институт биологии гена Российской академии наук (ИБГ РАН) Способ создания трансгенных растений с высоким уровнем экспрессии трансгенного белка
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
RU2496877C2 (ru) * 2011-12-15 2013-10-27 Общество с ограниченной ответственностью "Лаборатория медицинской биотехнологии" (ООО "ЛМБТ") ПЛАЗМИДНЫЙ ВЕКТОР pHYP С ПОВЫШЕННОЙ СЕГРЕГАЦИОННОЙ СТАБИЛЬНОСТЬЮ ДЛЯ ЭКСПРЕССИИ РЕКОМБИНАНТНОГО БЕЛКА, БАКТЕРИЯ - ПРОДУЦЕНТ ПРЕДШЕСТВЕННИКА РЕКОМБИНАНТНОГО БЕЛКА И СПОСОБ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО БЕЛКА
DK2825633T3 (da) * 2012-03-12 2019-05-20 Hanmi Science Co Ltd Fremgangsmåde til dyrkning af E. coli-celler til høj densitet
CN102604904B (zh) * 2012-03-14 2013-09-18 苏州汉酶生物技术有限公司 一种葡萄糖脱氢酶的生产方法
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
US9206390B2 (en) 2012-09-02 2015-12-08 Abbvie, Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
AU2014226126B2 (en) 2013-03-08 2019-02-14 Genzyme Corporation Continuous purification of therapeutic proteins
WO2014143205A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US8921526B2 (en) 2013-03-14 2014-12-30 Abbvie, Inc. Mutated anti-TNFα antibodies and methods of their use
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
WO2015051293A2 (en) 2013-10-04 2015-04-09 Abbvie, Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
US9714273B2 (en) * 2014-10-08 2017-07-25 Utah State University Expression systems and associated methods
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
CN111032850A (zh) 2017-04-27 2020-04-17 朱诺治疗学有限公司 寡聚粒子试剂及其使用方法
EP3843869A1 (en) 2018-08-31 2021-07-07 Genzyme Corporation Sterile chromatography resin and use thereof in manufacturing processes
CN110684101A (zh) * 2019-11-15 2020-01-14 上海松皓生物科技有限公司 一种重组水蛭素的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5558864A (en) 1991-03-06 1996-09-24 Merck Patent Gesellschaft Mit Beschrankter Haftung Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies

Also Published As

Publication number Publication date
EP0866876A1 (de) 1998-09-30
ATE213271T1 (de) 2002-02-15
NO982672D0 (no) 1998-06-10
HU227945B1 (en) 2012-06-28
AU716612B2 (en) 2000-03-02
JP4101879B2 (ja) 2008-06-18
JP2000501936A (ja) 2000-02-22
DE59608743D1 (de) 2002-03-21
JP4102422B2 (ja) 2008-06-18
CN1219203A (zh) 1999-06-09
CA2240097A1 (en) 1997-06-19
KR19990072037A (ko) 1999-09-27
SK283169B6 (sk) 2003-03-04
NO319090B1 (no) 2005-06-20
CA2240097C (en) 2005-07-26
SI0866876T1 (en) 2002-08-31
AR005035A1 (es) 1999-04-07
PL327188A1 (en) 1998-11-23
PL185665B1 (pl) 2003-06-30
UA61066C2 (en) 2003-11-17
EP0866876B1 (de) 2002-02-13
CZ291415B6 (cs) 2003-03-12
CZ165298A3 (cs) 1998-08-12
US6410270B1 (en) 2002-06-25
SK74098A3 (en) 1998-11-04
AU1032597A (en) 1997-07-03
HUP0000317A2 (hu) 2000-06-28
ES2171752T3 (es) 2002-09-16
HUP0000317A3 (en) 2001-09-28
JP2007185197A (ja) 2007-07-26
ZA9610384B (en) 1997-06-23
CN1117160C (zh) 2003-08-06
NO982672L (no) 1998-06-10
PT866876E (pt) 2002-07-31
BR9611937A (pt) 1999-03-02
KR100444735B1 (ko) 2004-11-10
RU2201455C2 (ru) 2003-03-27
WO1997021829A1 (de) 1997-06-19

Similar Documents

Publication Publication Date Title
DK0866876T3 (da) Fremgangsmåde til fremstilling af rekombinante proteiner i E.coli ved hjælp af fermentering i høje celletætheder
HK1017903A1 (en) Process for controlling sialylation of proteins produced by mammalian cell culture.
DK0408029T3 (da) Fremgangsmåde til fraktionering af plasmaprotein
DK0812357T3 (da) Fremgangsmåde til fremstilling af heteromultimere polypeptider
DK1142485T3 (da) Fremgangsmåde til forbedring af oplöseligheden af planteproteiner
TR199600357A2 (tr) Rekombinant simanlik (Ob) proteinleri.
BR9810654B1 (pt) mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
AU7566396A (en) Process for the preparation of peptides by way of streptavidin fusion proteins
FI973055A (fi) Soluja yhdistelmä-DNA-adenovirusten tuottamiseksi
EP0832973A3 (en) GTP-binding protein
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
DK0911416T3 (da) Fremgangsmåde til fremstilling af protein
FI954805A (fi) Menetelmiä insuliininkaltaisen kasvutekijän sitojaproteiinien käyttämiseksi
AU1686395A (en) (deltex) proteins, nucleic acids, and antibodies, and related methods and compositions
WO1996027665A3 (en) Neuron-restrictive silencer factor proteins
AU4367196A (en) Novel protein domain which binds tyrosine phosphorylated proteins
DK0789767T3 (da) Fremgangsmåde til fremstilling af oprensede papilomavirusproteiner
ATE285474T1 (de) Haemophilus adhäsionsproteinen
WO2000018909A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM)
BG95162A (bg) 4-или 5-заместени пиридин-2-карбонови киселини,метод за тяхното получаване и приложение
IS4957A (is) Hreinsuð prótein, samskeyttar DNA raðir og aðferðir til að stýra þroskun kaffiplantna
AU7193296A (en) Process for the ultrafiltration of biological matrices comprising peptides or proteins
EP0869802A4 (en) DELTEX PROTEINS, NUCLEIC ACIDS, AND ANTIBODIES OF VERTEBRATES, AS WELL AS THESE PROCEDURES AND COMPOSITIONS
EP0879879A3 (en) Polypeptide deformylase 1 (Def1)
FR2701953B1 (fr) Protéine de fusion multi-VIP et procédé de préparation de VIP recombinant.